Vaccine production in Africa key to pandemic-proofing the Continent
The unprecedented speed of development of the Covid-19 vaccines can be attributed to multiple factors including record levels of international collaboration and swift action on the part of many governments and regulatory bodies to provide a conducive framework.
As every nation across the globe faced impending economic doom, massive cross-sector funding materialised, allowing large-scale phased trials to be performed in parallel (multiple phases run simultaneously).
The accumulation of knowledge from decades of study on related viruses, including research which started after the SARS outbreaks of 2002 -2004, and the advent of mRNA-based vaccine technology further assisted in ensuring a swift response to halting the spread of the deadly virus.
The potential for factors that ena...